Accueil / Communiqués / Global Cell Culture (Media, Sera, Reagents) Markets, 2012-2018 & Forecast to 2022 –

Global Cell Culture (Media, Sera, Reagents) Markets, 2012-2018 & Forecast to 2022 –

Monday, January 14th 2019 at 12:58pm UTC

Cell Culture Markets (Media, Sera, Reagents) »
report has been
added to’s offering.

This report is focused on cell culture used in the research and
production of biopharmaceuticals, which includes stem cell therapeutics.
Worldwide demand for cell culture products for use in the research,
development, and production of biotherapeutic drugs is forecast to
expand during the forecast period.

Growth in the use of cell culture for biological research, vaccine
production, the production of therapeutic proteins, and emerging
regenerative medicine applications are driving the global cell culture
market. As second-generation biologics such as monoclonal antibodies
replace first-generation therapeutic proteins, there is also an
increased demand for more advanced in vitro cell culture techniques with
greater growing capacities.

Market data provided in Global Cell Culture Markets include:

  • Global Cell Culture Market, 2012-2022 (mil US$)
  • Global Cell Culture Market by Segment, 2012-2022 (mil US$) (Media,
    Sera, Reagents, Total)
  • Global Cell Culture Market by Region/Country, 2017
  • Global Cell Culture Market by Region/Country, 2022
  • Cell Culture Market Share by Company, 2017

Report Summary

  • Biopharmaceuticals Primary Driver of Cell Culture Market
  • Cell Culture Reagents Will Offer the Best Opportunities Through 2022
  • The Asia/Pacific Region Is Expected to Post the Fastest Growth

Company Profiles

In a market characterized by a high level of concentration, cell culture
product suppliers can increase market share and sustain margins by
partnering with pharmaceutical companies, or by acquiring smaller
producers or companies that manufacture specialty products.

The report profiles the major concerns in the cell culture
market, including:

  • Analytical Biological Services Incorporated
  • Athena Enzyme Systems
  • Avantor Incorporated
  • BD Biosciences
  • Bio-Techne Corporation
  • BioreclamationIVT LLC
  • Cell Essentials Incorporated
  • CellGenix GmbH
  • Corning Life Sciences
  • GE Healthcare Life Sciences
  • Gemini Bio-Products
  • InVitria
  • Irvine Scientific Sales Company Incorporated
  • Kohjin Bio Company Limited
  • Lonza Group Limited
  • MilliporeSigma
  • MP Biomedicals LLC
  • Nissui Pharmaceutical Company Limited
  • PromoCell GmbH
  • Quality Biological Incorporated
  • SBH Sciences Incorporated
  • ScienCell Research Laboratories Incorporated
  • Selexis SA
  • Serana Europe GmbH
  • STEMCELL Technologies Incorporated
  • Takara Bio Incorporated
  • Thermo Fisher Scientific Incorporated
  • Wisent Incorporated

Key Topics Covered:

1. Executive Summary

2. Biopharmaceuticals

3. Cell Culture Technologies

4. Cell Culture Consumables

5. Cell Culture Market

6. Company Profiles

7. Appendix: Company Directory

For more information about this report visit

Laura Wood, Senior Press Manager
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
For GMT Office Hours Call +353-1-416-8900
Topics: Biotechnology

Source: Research and Markets

Voir aussi

Fishawack poursuit son développement d’une offre de services hors pair avec l’acquisition de Dudnyk

Wednesday, March 20th 2019 at 9:25pm UTC KNUTSFORD, Angleterre–(BUSINESS WIRE)– Fishawack, une importante société experte …